• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

AIDS Treatments: Discounts Here to Stay

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-10-01-2001
Volume 0
Issue 0

Rio de Janeiro-The Brazilian health ministry will use its $35 million a year in savings on Roche’s newly discounted AIDS therapy to fund a program aimed at providing non-AIDS medicines to low-income families.

Related Videos
Related Content